Evidence map›Paper›PMID 32253259›Full record

ArticleGut2021

LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover.

Yuki Tanaka, Yuta Shimanaka, Andrea Caddeo, Takuya Kubo, Yanli Mao, Tetsuya Kubota, Naoto Kubota, Toshimasa Yamauchi, Rosellina Margherita Mancina, Guido Baselli and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Gut, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Precision pathophysiology in steatotic liver disease.Clinical and molecular hepatology · 2026
    Review
  4. Article
  5. Liver-Specific Suppression of PLA2G6/iPLAFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Silybin A fromTheranostics · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024
    Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 5 countries.

Yuki TanakaDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Yuta ShimanakaDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Andrea CaddeoDepartment of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Takuya KuboDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Yanli MaoDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Tetsuya KubotaDivision of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan.
Naoto KubotaDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Toshimasa YamauchiDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Rosellina Margherita MancinaDepartment of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Guido BaselliDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy.
Panu LuukkonenDepartment of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Jussi PihlajamäkiDepartment of Clinical Nutrition, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Hannele Yki-JärvinenDepartment of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Luca ValentiDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy.ORCID 0000-0001-8909-0345
Hiroyuki AraiDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Stefano RomeoDepartment of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden nozomu@mol.f.u-tokyo.ac.jp stefano.romeo@wlab.gu.se.ORCID 0000-0001-9168-4898
Nozomu KonoDepartment of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan nozomu@mol.f.u-tokyo.ac.jp stefano.romeo@wlab.gu.se.ORCID 0000-0002-0871-8477
The University of Tokyo · JPUniversity of Gothenburg · SEUniversity of Helsinki · FIUniversity of Milan · ITBunkyo University · JPJapan Agency for Medical Research and Development · JPSahlgrenska University Hospital · SEThe Institute of Medical Science, Asahi Life Foundation · JPUniversity of Eastern Finland · FIUniversity of Tokyo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveNon-alcoholic fatty liver disease (NAFLD) is a common prelude to cirrhosis and hepatocellular carcinoma. The genetic

designWe generated the hepatocyte-specific

resultsThe hepatocyte-specific

conclusionWe found a novel pathway fueling triglyceride synthesis in hepatocytes, by a direct metabolic flow of PI into triglycerides. Our findings provide an insight into the pathogenesis and therapeutics of NAFLD.

Indexed as

AcyltransferasesAnimalsCell Culture TechniquesDisease Models, AnimalHepatocytesHumansLipid MetabolismMembrane ProteinsMiceMice, KnockoutNon-alcoholic Fatty Liver DiseasePhosphatidylinositolsTriglyceridesAcyltransferaseslysophosphatidylinositol acyltransferaseMBOAT7 protein, humanMboat7 protein, mouseMembrane ProteinsPhosphatidylinositolsTriglyceridesfatty liverhepatic fibrosislipid metabolismlipids

Identifiers

PMID32253259
PMCPMC7788230
OpenAlexW3014941724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.